- Home
- LNTH vs ASND Comparison
LNTH vs ASND Comparison
Compare LNTH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- ASND
- Stock Information
- Founded
- LNTH 1956
- ASND 2006
- Country
- LNTH United States
- ASND Denmark
- Employees
- LNTH N/A
- ASND N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- LNTH Health Care
- ASND Health Care
- Exchange
- LNTH Nasdaq
- ASND Nasdaq
- Market Cap
- LNTH 7.2B
- ASND 7.7B
- IPO Year
- LNTH 2015
- ASND 2015
- Fundamental
- Price
- LNTH $90.52
- ASND $129.81
- Analyst Decision
- LNTH Strong Buy
- ASND Strong Buy
- Analyst Count
- LNTH 7
- ASND 13
- Target Price
- LNTH $121.86
- ASND $191.77
- AVG Volume (30 Days)
- LNTH 1.6M
- ASND 495.4K
- Earning Date
- LNTH 11-06-2024
- ASND 11-14-2024
- Dividend Yield
- LNTH N/A
- ASND N/A
- EPS Growth
- LNTH 304.57
- ASND N/A
- EPS
- LNTH 6.02
- ASND N/A
- Revenue
- LNTH $1,496,799,000.00
- ASND $365,187,374.00
- Revenue This Year
- LNTH $19.56
- ASND $10.30
- Revenue Next Year
- LNTH $6.32
- ASND $90.02
- P/E Ratio
- LNTH $15.03
- ASND N/A
- Revenue Growth
- LNTH 24.15
- ASND 115.54
- 52 Week Low
- LNTH $50.20
- ASND $90.13
- 52 Week High
- LNTH $126.89
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- LNTH 45.56
- ASND 53.83
- Support Level
- LNTH $75.00
- ASND $119.09
- Resistance Level
- LNTH $118.21
- ASND $125.52
- Average True Range (ATR)
- LNTH 5.13
- ASND 5.52
- MACD
- LNTH 0.13
- ASND 0.41
- Stochastic Oscillator
- LNTH 38.71
- ASND 78.66
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.